skip to main content

ALL Late Effects Surveillance — RACP Paediatrics MCQ

Instant feedback + full explanation. One question, done properly.

ModerateHaematology & OncologyALL Late Effects SurveillanceRACP Paediatrics

A 10-year-old with ALL completes 2 years of maintenance chemotherapy. What long-term follow-up surveillance is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Lifelong follow-up for late effects: cardiac function, neurocognitive, endocrine, bone health, second malignancy screening, and fertility

ALL survivors require lifelong late-effects monitoring: cardiac (anthracycline-related cardiomyopathy), neurocognitive (cranial radiation/intrathecal MTX), endocrine (growth, thyroid, gonadal function), bone density, second malignancy risk, and psychosocial wellbeing. Survivorship care plans should be provided.

Reference: ANZCHOG – 2024 – ALL Survivorship Guidelines